| - Industry | - Sector | Mr. Darren J. Lopez M.B.A. CEO | OTC PINK Exchange | - ISIN |
| United States Country | - Employees | - Last Dividend | 26 Sep 2025 Last Split | - IPO Date |
BioScience Health Innovations, Inc. is at the forefront of healthcare by focusing on the delivery of clinically validated, cost-effective products that address bacterial and viral threats while promoting neurological health throughout the United States. With an extensive product range designed for various health challenges, including dementia, Alzheimer's, ADHD, long COVID, traumatic brain injury, cognitive decline, and sleep disorders, the company is committed to enhancing health and well-being.
Under the leadership of CEO Darren Lopez, BioScience Health Innovations, Inc. operates within the pharmaceuticals sector, contributing to the rising demand for innovative health solutions that prioritize natural defenses and cognitive enhancement. The company utilizes diverse distribution methods, including sales through Amazon, online wholesale platforms, private labels, and direct sales channels to reach customers effectively.